Barley for Food and Health: Science, Technology, and Products
Barley for Food and Health: Science, Technology, and Products
Barley for Food and Health: Science, Technology, and Products
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
194 HEALTH BENEFITS OF BARLEY FOODS<br />
BENEFICIAL EFFECTS OF RESISTANT STARCH IN BARLEY ON<br />
THE INTESTINAL TRACT<br />
The indigestible fiber components of barley, especially β-glucan,aswellasRS,<br />
progress through the digestive tract on into the large intestine. Fermentation of<br />
this material by microflora then occurs, resulting in <strong>for</strong>mation of short-chain fatty<br />
acids (SCFA), especially butyrate <strong>and</strong> propionate (Topping <strong>and</strong> Clifton 2001).The<br />
benefits of these fatty acids in the large intestine are healthy colonic mucosa,<br />
<strong>and</strong> provision of an energy source <strong>for</strong> epithelial cells (Topping et al. 2003).<br />
Dongowski et al. (2002) investigated the effects of a high-amylose barley <strong>and</strong> PW<br />
barley, compared with maize starch, a high-RS commercial product, <strong>and</strong> a control<br />
diet with no barley. These materials were extruded to prepare experimental diets<br />
<strong>for</strong> rats. All of the animals fed barley diets thrived better <strong>and</strong> had greater intestinal<br />
mass than controls. SCFAs (i.e., acetic, propionic, <strong>and</strong> butyric) were higher in<br />
cecal <strong>and</strong> colon contents of animals fed the test diets. The more acid conditions<br />
indicated a smaller proportion of secondary bile acids, believed to be promoting<br />
factors in colon cancer. Bird et al. (2004b) fed stabilized whole-grain barley<br />
flours from Himalaya 292, the high-amylose barley cited previously (Bird et al.<br />
2004a), with two other barleys, <strong>and</strong> either wheat or oat bran to rats, to determine<br />
the effects of these feeds on intestinal SCFAs. Although there were independent<br />
differences between animals fed different diets, colonic SCFAs were consistently<br />
higher <strong>and</strong> pH was lower in those fed Himalaya 292 barley than all other diets.<br />
Results were attributed to the greater RS content in this barley cultivar, due to<br />
its reduced amylopectin <strong>and</strong> increased amylose content as well as having a high<br />
β-glucan content. More recently, Bird et al. (2007) compared the effects of foods<br />
made from whole-grain Himalaya 292 with those made from whole-grain wheat<br />
or refined cereal. Biomarkers of bowel health in healthy subjects (fecal weight,<br />
fecal concentration of butyrate, SCFA excretion, <strong>and</strong> fecal p-cresol concentration)<br />
were all significantly different between groups <strong>and</strong> indicative of improved bowel<br />
health in subjects who consumed barley diets. The beneficial health benefits were<br />
attributed to the presence of resistant starch.<br />
SUMMARY<br />
<strong>Barley</strong> has been shown in animal studies <strong>and</strong> human clinical trials to be an ordinary<br />
food product that can effectively normalize blood cholesterol. β-Glucan, a<br />
significant part of the dietary fiber in barley, is the most important component<br />
<strong>for</strong> lowering blood cholesterol concentration. It is generally believed that this<br />
beneficial effect is the result of increased intestinal viscosity, delaying absorption<br />
of food fat <strong>and</strong> binding bile acids, which cycle with body cholesterol. Data<br />
from studies with extracted β-glucans have not been as consistent in cholesterollowering<br />
efficacy as with β-glucans in the natural state in the grain or grain products.<br />
Further research in extraction procedures to obtain semipurified β-glucan<br />
with intact physiochemical properties will no doubt improve the efficacy of the<br />
products.